Advertisement
Screener

Zymergen Inc. Stock-Based Compensation

Zymergen Inc. Stock-Based Compensation

Zymergen Inc. reported Stock-Based Compensation of $16.03 million for the 6-month period ending 2022-06-30, per its 10-Q filed 2022-08-15.

Discontinued › Cash Flow › Operating Activities

us-gaap:ShareBasedCompensation · last filed 2022-08-15

  • Zymergen Inc. share-based payment arrangement, noncash expense for the quarter ending 2022-06-30 was $8.64M, a 24.08% increase year-over-year.
  • Zymergen Inc. share-based payment arrangement, noncash expense for the quarter ending 2022-03-31 was $7.39M, a 228.05% increase year-over-year.
  • Zymergen Inc. share-based payment arrangement, noncash expense for the quarter ending 2021-12-31 was $6.67M, a 374.80% increase year-over-year.
  • Zymergen Inc. share-based payment arrangement, noncash expense for the quarter ending 2021-09-30 was $5.42M, a 376.03% increase year-over-year.
  • Zymergen Inc. share-based payment arrangement, noncash expense for fiscal 2021 was $21.31M, a 341.31% increase from fiscal 2020.
  • Zymergen Inc. share-based payment arrangement, noncash expense for fiscal 2020 was $4.83M, a 20.36% increase from fiscal 2019.
  • Zymergen Inc. share-based payment arrangement, noncash expense for fiscal 2019 was $4.01M.
Period endShare-based Payment Arrangement, Noncash Expense 3 monthShare-based Payment Arrangement, Noncash Expense 6 monthShare-based Payment Arrangement, Noncash Expense 9 monthShare-based Payment Arrangement, Noncash Expense 12 month
2022-06-30$8.64M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15
$16.03M
10-Q · filed 2022-08-15
$22.70M
derived: sum of 3 quarters · filed 2022-08-15
$28.13M
derived: sum of 4 quarters · filed 2022-08-15
2022-03-31$7.39M
10-Q · filed 2022-05-12
$14.06M
derived: sum of 2 quarters · filed 2022-05-12
$19.48M
derived: sum of 3 quarters · filed 2022-05-12
$26.45M
derived: sum of 4 quarters · filed 2022-08-15
2021-12-31$6.67M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30
$12.09M
derived: sum of 2 quarters · filed 2022-03-30
$19.06M
derived: sum of 3 quarters · filed 2022-08-15
$21.31M
10-K · filed 2022-03-30
2021-09-30$5.42M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15
$12.39M
derived: sum of 2 quarters · filed 2022-08-15
$14.64M
10-Q · filed 2021-11-15
$16.05M
derived: sum of 4 quarters · filed 2022-08-15
2021-06-30$6.96M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15
$9.22M
10-Q · filed 2022-08-15
$10.62M
derived: sum of 3 quarters · filed 2022-08-15
$11.76M
derived: sum of 4 quarters · filed 2022-08-15
2021-03-31$2.25M
10-Q · filed 2022-05-12
$3.66M
derived: sum of 2 quarters · filed 2022-05-12
$4.80M
derived: sum of 3 quarters · filed 2022-05-12
$6.04M
derived: sum of 4 quarters · filed 2022-05-12
2020-12-31$1.41M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30
$2.54M
derived: sum of 2 quarters · filed 2022-03-30
$3.79M
derived: sum of 3 quarters · filed 2022-03-30
$4.83M
10-K · filed 2022-03-30
2020-09-30$1.14M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15
$2.38M
derived: sum of 2 quarters · filed 2021-11-15
$3.42M
10-Q · filed 2021-11-15
2020-06-30$1.24M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16
$2.29M
10-Q · filed 2021-08-16
2020-03-31$1.04M
10-Q · filed 2021-05-27
2019-12-31$4.01M
10-K · filed 2022-03-30